Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
JACC. Heart Failure
|
December 20, 2015
Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry
Michael Arzt, Holger Woehrle, Olaf Oldenburg, et al.
European Journal of Heart Failure
|
February 21, 2006
Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others"
Ronnie Willenheimer, Henry Krum, Dirk J van Veldhuisen, et al.
Journal of the American Heart Association
|
December 1, 2017
Phenotyping of Sleep-Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction-the SchlaHF Registry
Michael Arzt, Olaf Oldenburg, Andrea Graml, et al.
International Journal of Cardiology
|
November 1, 2011
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population
Wolfram Doehner, Erland Erdmann, Richard Cairns, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
October 15, 2008
ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting
Markus Flesch, Stephan Knipp, Gerhard Kessler, et al.
European Heart Journal
|
June 20, 2006
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]
John G F Cleland, Jean-Claude Daubert, Erland Erdmann, et al.
The New England Journal of Medicine
|
March 9, 2005
The effect of cardiac resynchronization on morbidity and mortality in heart failure
John G F Cleland, Jean-Claude Daubert, Erland Erdmann, et al.
Journal of the American College of Cardiology
|
March 3, 2012
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension
Mathias C Brandt, Felix Mahfoud, Sara Reda, et al.
Cost Effectiveness and Resource Allocation : C/E
|
May 7, 2009
Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective
Werner A Scherbaum, Gordon Goodall, Katrina M Erny-Albrecht, et al.
European Journal of Heart Failure
|
May 4, 2012
Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial
John G F Cleland, Nick Freemantle, Erland Erdmann, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
JACC. Heart Failure
|
December 20, 2015
Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry
Michael Arzt, Holger Woehrle, Olaf Oldenburg, et al.
European Journal of Heart Failure
|
February 21, 2006
Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others"
Ronnie Willenheimer, Henry Krum, Dirk J van Veldhuisen, et al.
Journal of the American Heart Association
|
December 1, 2017
Phenotyping of Sleep-Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction-the SchlaHF Registry
Michael Arzt, Olaf Oldenburg, Andrea Graml, et al.
International Journal of Cardiology
|
November 1, 2011
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population
Wolfram Doehner, Erland Erdmann, Richard Cairns, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
October 15, 2008
ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting
Markus Flesch, Stephan Knipp, Gerhard Kessler, et al.
European Heart Journal
|
June 20, 2006
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]
John G F Cleland, Jean-Claude Daubert, Erland Erdmann, et al.
The New England Journal of Medicine
|
March 9, 2005
The effect of cardiac resynchronization on morbidity and mortality in heart failure
John G F Cleland, Jean-Claude Daubert, Erland Erdmann, et al.
Journal of the American College of Cardiology
|
March 3, 2012
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension
Mathias C Brandt, Felix Mahfoud, Sara Reda, et al.
Cost Effectiveness and Resource Allocation : C/E
|
May 7, 2009
Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective
Werner A Scherbaum, Gordon Goodall, Katrina M Erny-Albrecht, et al.
European Journal of Heart Failure
|
May 4, 2012
Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial
John G F Cleland, Nick Freemantle, Erland Erdmann, et al.
Page
of 14